Anne Moreau

2.8k total citations
40 papers, 1.3k citations indexed

About

Anne Moreau is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Anne Moreau has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 7 papers in Immunology. Recurrent topics in Anne Moreau's work include Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Anne Moreau is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Anne Moreau collaborates with scholars based in France, Canada and United States. Anne Moreau's co-authors include Karima Mokhtari, M. Kujas, Philippe Colombat, Khê Hoang‐Xuan, Wafae Iraqi, Catherine Sautès‐Fridman, Antoine Martin, Emmanuelle Crinière, Dominique Heymann and Sophie Camilleri‐Broët and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Journal of Clinical Microbiology.

In The Last Decade

Anne Moreau

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Moreau France 16 350 312 283 257 221 40 1.3k
DS Snyder United States 17 247 0.7× 368 1.2× 124 0.4× 168 0.7× 205 0.9× 29 1.5k
Ernesto Ayala United States 20 409 1.2× 552 1.8× 91 0.3× 348 1.4× 280 1.3× 140 1.5k
M.C. Copin France 17 237 0.7× 259 0.8× 129 0.5× 207 0.8× 59 0.3× 42 1.1k
Ralf Ulrich Trappe Germany 26 773 2.2× 1.3k 4.2× 182 0.6× 163 0.6× 208 0.9× 80 2.1k
Joan Bargay Spain 24 172 0.5× 509 1.6× 88 0.3× 241 0.9× 372 1.7× 72 2.0k
Robert L. Saylors United States 23 113 0.3× 550 1.8× 389 1.4× 159 0.6× 286 1.3× 36 1.9k
Herbert G. Sayer Germany 24 218 0.6× 492 1.6× 54 0.2× 403 1.6× 533 2.4× 90 2.1k
Doug Stewart Canada 15 183 0.5× 273 0.9× 136 0.5× 162 0.6× 457 2.1× 25 1.0k
Andrea Assanelli Italy 18 373 1.1× 263 0.8× 325 1.1× 455 1.8× 249 1.1× 47 1.2k
Stephen J. Forman United States 19 185 0.5× 298 1.0× 76 0.3× 203 0.8× 127 0.6× 34 962

Countries citing papers authored by Anne Moreau

Since Specialization
Citations

This map shows the geographic impact of Anne Moreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Moreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Moreau more than expected).

Fields of papers citing papers by Anne Moreau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Moreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Moreau. The network helps show where Anne Moreau may publish in the future.

Co-authorship network of co-authors of Anne Moreau

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Moreau. A scholar is included among the top collaborators of Anne Moreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Moreau. Anne Moreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perret, Raul, Valérie Velasco, Francisco Llamas‐Gutierrez, et al.. (2023). Giant Cell Tumors With HMGA2::NCOR2 Fusion. The American Journal of Surgical Pathology. 47(7). 801–811. 13 indexed citations
2.
Peuvrel, L., A. Brocard, M. Saint‐Jean, et al.. (2016). Dramatic response of an inoperable Merkel cell carcinoma with imatinib. JAAD Case Reports. 2(1). 16–18. 6 indexed citations
3.
Emile, Jean‐François, Frédéric Charlotte, Catherine Chassagne‐Clément, et al.. (2016). Classification histologique et altérations moléculaires des histiocytoses. La Presse Médicale. 46(1). 46–54. 6 indexed citations
4.
Baud’huin, Marc, Céline Charrier, Anne Moreau, et al.. (2010). Interleukin‐34 is expressed by giant cell tumours of bone and plays a key role in RANKL‐induced osteoclastogenesis. The Journal of Pathology. 221(1). 77–86. 127 indexed citations
5.
Fang, Cheng, Caroline Ballet, Anne‐Sophie Dugast, et al.. (2009). Autoimmune responses against renal tissue proteins in long-term surviving allograft recipients. Transplant International. 22(11). 1091–1099.
6.
Gallot, Géraldine, M. Hamidou, Béatrice Clemenceau, et al.. (2006). T cell repertoire and Epstein–Barr virus-specific T cell response in chronic active Epstein–Barr virus infection: A case study. Clinical Immunology. 119(1). 79–86. 2 indexed citations
7.
Hamidou, M., Marie Audrain, A. Masseau, C. Agard, & Anne Moreau. (2006). Anti-topoisomerase I antibodies in systemic lupus erythematosus as a marker of severe nephritis. Clinical Rheumatology. 25(4). 542–543. 13 indexed citations
8.
Camilleri‐Broët, Sophie, Emmanuelle Crinière, Philippe Broët, et al.. (2005). A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood. 107(1). 190–196. 271 indexed citations
9.
Galmiche, Louise, et al.. (2004). Angiosarcome primitif surrénalien. Annales de Pathologie. 24(4). 371–373. 11 indexed citations
10.
Renaudin, Karine, Anne Moreau, & Françoise Buzelin. (2002). [Pathologic anatomy of infiltrating epithelial tumors of the bladder].. PubMed. 12(5). 787–802. 1 indexed citations
11.
Hamidou, M., et al.. (2002). Systemic Vasculitis With Lymphocytic Temporal Arteritis and Toxocara canis Infection. Archives of Internal Medicine. 162(13). 1521–1521. 21 indexed citations
12.
Brouard, Sophie, Bernard Vanhove, Katia Gagne, et al.. (2000). T cell repertoire alterations in allograft and xenograft rejection processes. Transplantation Proceedings. 32(5). 924–925. 1 indexed citations
13.
Brouard, Sophie, María Cristina Cuturi, Pascale Pignon, et al.. (1999). PROLONGATION OF HEART XENOGRAFT SURVIVAL IN A HAMSTER-TO-RAT MODEL AFTER THERAPY WITH A RATIONALLY DESIGNED IMMUNOSUPPRESSIVE PEPTIDE1. Transplantation. 67(12). 1614–1618. 15 indexed citations
14.
Milpied, Nöel, Marianne Coste‐Burel, Françoise Accard, et al.. (1999). Epstein–Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation. Bone Marrow Transplantation. 23(6). 629–630. 54 indexed citations
15.
Ponge, T., David Boutoille, Anne Moreau, et al.. (1998). Systemic vasculitis in a patient with small-cell neuroendocrine bronchial cancer. European Respiratory Journal. 12(5). 1228–1229. 16 indexed citations
16.
Louvet, S, A. Dompmartin, Xavier Troussard, et al.. (1996). SPECTRUM OF CD30 LYMPHOPROLIFERATIVE DISEASES FROM LYMPHOMATOID PAPULOSIS TO ANAPLASTIC LARGE CELL LYMPHOMA. International Journal of Dermatology. 35(12). 842–848. 11 indexed citations
17.
Dompmartin, A., et al.. (1995). RECURRING POSTOPERATIVE PYODERMA GANGRENOSUM. International Journal of Dermatology. 34(9). 647–650. 18 indexed citations
18.
Dompmartin, A., et al.. (1994). CUTANEOUS MALACOPLAKIA. International Journal of Dermatology. 33(8). 538–542. 9 indexed citations
19.
Moreau, Anne, et al.. (1972). Sevrage et réduction de doses de corticoïdes sous cromoglycate de sodium.. 48(1). 1 indexed citations
20.
Moreau, Anne, et al.. (1972). [Withdrawal and reduction of doses of corticoids with sodium cromoglycate].. PubMed. 48(1). 15–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by DS Snyder Breakdown of academic impact, for papers by Ernesto Ayala Breakdown of academic impact, for papers by M.C. Copin Breakdown of academic impact, for papers by Ralf Ulrich Trappe Breakdown of academic impact, for papers by Joan Bargay Breakdown of academic impact, for papers by Robert L. Saylors Breakdown of academic impact, for papers by Herbert G. Sayer Breakdown of academic impact, for papers by Doug Stewart Breakdown of academic impact, for papers by Andrea Assanelli Breakdown of academic impact, for papers by Stephen J. Forman
Rankless by CCL
2026